“The FDA's filing acceptance of Dr. Reddy's proposed denosumab biosimilar marks an important milestone in bringing this biosimilar medication to more patients throughout the U.S.,” said Milan ...

Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as "Dr. Reddy's") and Alvotech (NASDAQ: ALVO), a global biotech ...

As Holi 2025 is celebrated on March 14 this year, taking care of your skin is important and one that requires expert tips ...

The acquisition will be funded through the Initial Public Offer proceeds raised by Senores Pharmaceuticals Limited.

In response to the alarming rise in measles cases across New Mexico and Texas, HealthTrackRx, the nation's premier provider of molecular diagnostic testing, today announced the development of a ...

Stocked on the kitchen shelves, a bottle of hair oil signifies a time-honoured grooming ritual sans any artificial additives ...

J Clin Aesthet Dermatol. 2019;12(10):E53-E57. American Academy of Dermatology Association. Retinoid or retinol? Reddy S, Brahmbhatt H. A narrative review on the role of acids, steroids ...

On this International Women's Day, six successful female entrepreneurs share their experiences, obstacles, and the insights ...

With the agreement, Cosette brings into its fold a clutch of women’s healthcare and dermatology brands—plus ... but nonmarketed drugs—to Dr. Reddy’s Laboratories for up to $105 million.

Licensed from Dr. Reddy’s in 2021, Journey Medical successfully navigated clinical trials and FDA approval, positioning itself as a major player in dermatology. With 79% of surveyed ...